Omeros Morgan Bond

OMER Stock  USD 7.63  0.86  10.13%   
At this time, Omeros' Short and Long Term Debt Total is relatively stable compared to the past year. As of 12/15/2024, Net Debt is likely to grow to about 372.2 M, while Long Term Debt Total is likely to drop slightly above 159.7 M. . Omeros' financial risk is the risk to Omeros stockholders that is caused by an increase in debt.
 
Debt Ratio  
First Reported
2010-12-31
Previous Quarter
0.89428687
Current Value
0.77
Quarterly Volatility
0.63326292
 
Credit Downgrade
 
Yuan Drop
 
Covid
At this time, Omeros' Liabilities And Stockholders Equity is relatively stable compared to the past year. As of 12/15/2024, Non Current Liabilities Total is likely to grow to about 367.4 M, while Total Current Liabilities is likely to drop slightly above 35.4 M.
  
Check out the analysis of Omeros Fundamentals Over Time.
To learn how to invest in Omeros Stock, please use our How to Invest in Omeros guide.
View Bond Profile
Given the importance of Omeros' capital structure, the first step in the capital decision process is for the management of Omeros to decide how much external capital it will need to raise to operate in a sustainable way. Once the amount of financing is determined, management needs to examine the financial markets to determine the terms in which the company can boost capital. This move is crucial to the process because the market environment may reduce the ability of Omeros to issue bonds at a reasonable cost.
Popular NameOmeros Morgan Stanley 3591
SpecializationPharmaceuticals, Biotechnology & Life Sciences
Equity ISIN CodeUS6821431029
Bond Issue ISIN CodeUS61744YAK47
S&P Rating
Others
Maturity Date22nd of July 2028
Issuance Date24th of July 2017
Coupon3.591 %
View All Omeros Outstanding Bonds

Omeros Outstanding Bond Obligations

Understaning Omeros Use of Financial Leverage

Omeros' financial leverage ratio measures its total debt position, including all of its outstanding liabilities, and compares it to Omeros' current equity. If creditors own a majority of Omeros' assets, the company is considered highly leveraged. Understanding the composition and structure of Omeros' outstanding bonds gives an idea of how risky it is and if it is worth investing in.
Last ReportedProjected for Next Year
Short and Long Term Debt Total361.6 M379.7 M
Net Debt354.5 M372.2 M
Short Term Debt13.7 M12 M
Long Term Debt254 M266.7 M
Long Term Debt Total254 M159.7 M
Short and Long Term Debt108.5 M69.3 M
Net Debt To EBITDA(2.17)(2.06)
Debt To Equity(13.54)(12.86)
Interest Debt Per Share 5.62  5.90 
Debt To Assets 0.89  0.77 
Long Term Debt To Capitalization 1.08  1.14 
Total Debt To Capitalization 1.08  1.00 
Debt Equity Ratio(13.54)(12.86)
Debt Ratio 0.89  0.77 
Cash Flow To Debt Ratio 0.22  0.23 
Please read more on our technical analysis page.

Pair Trading with Omeros

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Omeros position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Omeros will appreciate offsetting losses from the drop in the long position's value.

Moving together with Omeros Stock

  0.85ESPR Esperion TherapeuticsPairCorr
  0.74BMY Bristol Myers SquibbPairCorr

Moving against Omeros Stock

  0.84AMGN Amgen IncPairCorr
  0.75PFE Pfizer Inc Fiscal Year End 4th of February 2025 PairCorr
  0.74AVDL Avadel PharmaceuticalsPairCorr
  0.68JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.66TTOO T2 BiosystmsPairCorr
The ability to find closely correlated positions to Omeros could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Omeros when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Omeros - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Omeros to buy it.
The correlation of Omeros is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Omeros moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Omeros moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Omeros can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Omeros Stock Analysis

When running Omeros' price analysis, check to measure Omeros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omeros is operating at the current time. Most of Omeros' value examination focuses on studying past and present price action to predict the probability of Omeros' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omeros' price. Additionally, you may evaluate how the addition of Omeros to your portfolios can decrease your overall portfolio volatility.

What is Financial Leverage?

Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.

Leverage and Capital Costs

The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.

Benefits of Financial Leverage

Leverage provides the following benefits for companies:
  • Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
  • It provides a variety of financing sources by which the firm can achieve its target earnings.
  • Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.
By borrowing funds, the firm incurs a debt that must be paid. But, this debt is paid in small installments over a relatively long period of time. This frees funds for more immediate use in the stock market. For example, suppose a company can afford a new factory but will be left with negligible free cash. In that case, it may be better to finance the factory and spend the cash on hand on inputs, labor, or even hold a significant portion as a reserve against unforeseen circumstances.

The Risk of Financial Leverage

The most obvious and apparent risk of leverage is that if price changes unexpectedly, the leveraged position can lead to severe losses. For example, imagine a hedge fund seeded by $50 worth of investor money. The hedge fund borrows another $50 and buys an asset worth $100, leading to a leverage ratio of 2:1. For the investor, this is neither good nor bad -- until the asset price changes. If the asset price goes up 10 percent, the investor earns $10 on $50 of capital, a net gain of 20 percent, and is very pleased with the increased gains from the leverage. However, if the asset price crashes unexpectedly, say by 30 percent, the investor loses $30 on $50 of capital, suffering a 60 percent loss. In other words, the effect of leverage is to increase the volatility of returns and increase the effects of a price change on the asset to the bottom line while increasing the chance for profit as well.